Page last updated: 2024-10-25

dequalinium and Myasthenia Gravis

dequalinium has been researched along with Myasthenia Gravis in 1 studies

Dequalinium: A topical bacteriostat that is available as various salts. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration.
dequalinium : A quinolinium ion comprising decane in which one methyl hydrogen at each end of the molecule has been replaced by a 4-amino-2-methylquinolin-1-yl group.

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GRAHAM, WJ1
GRANT, AP1

Other Studies

1 other study available for dequalinium and Myasthenia Gravis

ArticleYear
Dequalinium in myasthenia gravis.
    British medical journal, 1959, Jan-17, Volume: 1, Issue:5115

    Topics: Ammonium Compounds; Anti-Infective Agents, Local; Dequalinium; Humans; Myasthenia Gravis; Quaternary

1959